2024 21 USC 360bbb-8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2023 21 USC 360bbb-8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2022 21 USC 360bbb-8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2021 21 USC 360bbb-8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2020 21 USC 360bbb-8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2018 21 USC 360bbb-8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2017 21 USC 360bbb–8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2015 21 USC 360bbb–8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2014 21 USC 360bbb-8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2013 21 USC 360bbb-8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

2012 21 USC 360bbb-8 – Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments